Search filters

Filters
Clear All

Phase

  • 1
  • 2
  • 2
  • 11
  • 16
  • 7
  • 16

Found 16 dm-rheumatology trials

A listing of dm-rheumatology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
T-Cell Response to Tetanus Vaccine
18 years - 100 years
Accepts healthy volunteer
All genders
This study aims to understand how your body forms a protective response after vaccination. We are studying the immune response to the tetanus/diphtheria vaccine.
99 years or below
All genders
Phase 2
To determine if IMVT-1402 is safe and effective for the treatment of adults with primary Sjogren's disease. 
99 years or below
All genders
To assess the safety and efficacy of tulisokibart in patients with psoriatic arthritis. Subjects will be randomized to receive one of three doses vs. placebo. Outcomes will be assessed with patient-reported questionnaires and clinical assessments of disease activity.
18 years - 99 years
Accepts healthy volunteer
All genders
The research study is being conducted to better understand the role of immune cells in the development of joint inflammation in patients with inflammatory arthritis and to identify immune predictors in tissue and fluid from joints and blood that can be used in the clinic to assign the best therapy …
99 years or below
All genders
This study is an open label extension study of an ongoing randomized controlled clinical study, 218224 which aims to assess the efficacy of belimumab on reducing the decline in lung function in participants with interstitial lung disease associated with diffuse cutaneous systemic sclerosis.
18 years or above
All genders
Observational
This study investigates how cancer treatment with immune checkpoint inhibitors (ICI) can lead to the development of autoimmunity. The purpose is to understand the genetic and immune system characteristics that cause some cancer patients to experience immune-related adverse events (irAE) after receiving checkpoint inhibitor therapy.Participants will provide peripheral blood and …
11 - 16 of 16